Evidence map›Paper›PMID 26048664›Full record

Trial reportThe Journal of allergy and clinical immunology2015

Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients.

Verena Niederberger, Katharina Marth, Julia Eckl-Dorna, Margarete Focke-Tejkl, Milena Weber, Wolfgang Hemmer, Uwe Berger, Angela Neubauer, Frank Stolz, Rainer Henning and 1 more

Abstract readClinical TrialLetter
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Recent advances in allergen immunotherapy.Chinese medical journal · 2026
    Review
  5. Article
  6. Peptide immunotherapy for aeroallergens.Allergy and asthma proceedings · 2023
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Recombinant allergens for immunotherapy: state of the art.Current opinion in allergy and clinical immunology · 2019
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Single recombinant and purified major allergens and peptides: How they are made and how they change allergy diagnosis and treatment.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2017
    Review
  18. Review
  19. Molecular aspects of allergens in atopic dermatitis.Current opinion in allergy and clinical immunology · 2017
    Review
  20. [Innovative forms of specific immunotherapy].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Verena NiederbergerDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria. Electronic address: verena.niederberger@meduniwien.ac.at.
Katharina MarthDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Julia Eckl-DornaDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
Margarete Focke-TejklDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Milena WeberDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Wolfgang HemmerFAZ - Floridsdorf Allergy Center, Vienna, Austria.
Uwe BergerDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
Angela NeubauerBiomay AG, Vienna, Austria.
Frank StolzBiomay AG, Vienna, Austria.
Rainer HenningBiomay AG, Vienna, Austria.
Rudolf ValentaDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Centre for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.

Funding

Austrian Science Fund FWF F 4605
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultDesensitization, ImmunologicFemaleHumansMalePeptidesPlant ProteinsRhinitis, Allergic, SeasonalSkin TestsVaccinesPeptidesPlant ProteinsVaccines

Identifiers

PMID26048664
PMCPMC6536382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.